9
Disclosures
Feb 6, 2026 — May 29, 2026
Date Range
PRIME
Market Segment
Services
Sector
Disclosures
| Date | Type | Headline | |
|---|---|---|---|
| May 29 | Business Transfer | SHIN Nippon Biomedical Announces Business Transfer | |
| May 11 | Earnings | SHIN Nippon Biomedical LABORATORIES Reports Revenue Growth Despite Lower Operating Profit | |
| May 11 | Earnings | SHIN Nippon Biomedical Reports Earnings Results | |
| May 11 | Other | SHIN Nippon Biomedical SCIENTIFIC HOSTS BOARD MEETING TO DISCUSS ATZUMI™ BUSINESS STRATEGY | |
| Apr 30 | Other | SHIN Nippon Biomedical TO SEEK SHAREHOLDER APPROVAL FOR CORPORATE GOVERNANCE CHANGES | |
| Apr 30 | Other | SHIN Nippon Biomedical APPOINTS NEW CEO; ROLE CHANGES EFFECTIVE JUNE 26 | |
| Feb 6 | Earnings | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. Reports Q3 FY2026 Earnings Presentation: Revenue of 222 million | |
| Feb 6 | Earnings | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. Reports Q3 FY2026 Earnings Presentation: Revenue of 500 million | |
| Feb 6 | Forecast | FY2026/3 Full-Year Earnings Forecast Revision |
Disclosure Types
Earnings: 4 Other: 3 Business Transfer: 1 Forecast: 1